Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?

Surbonn, 1988, Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy. significance and management, J. Clin. Oncol., 6, 1832, 10.1200/JCO.1988.6.12.1832 Foote, 1980, Residual abdominal masses following treatment of Hodgkin's disease, Australas. Radiol., 24, 151, 10.1111/j.1440-1673.1980.tb02175.x Katz, 1977, Masses mediastinales residuelles post-radiotherapiques au cours de la maladie de Hodgkin, Ann. Radiol., 20, 667 Chen, 1987, Residual fibrous masses in treated Hodgkin's disease, Cancer, 60, 407, 10.1002/1097-0142(19870801)60:3<407::AID-CNCR2820600321>3.0.CO;2-N Jochelson, 1985, The significance of the residual mediastinal mass in treated Hodgkin's disease, J. Clin. Oncol., 3, 637, 10.1200/JCO.1985.3.5.637 Radford, 1988, The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease, J. Clin. Oncol., 6, 940, 10.1200/JCO.1988.6.6.940 Loeffler, 1998, Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group, J. Clin. Oncol., 16, 818, 10.1200/JCO.1998.16.3.818 Aviles, 1994, Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma, Int. J. Radiat. Oncol. Biol. Phys., 30, 799, 10.1016/0360-3016(94)90352-2 Gustavsson, 1990, Late cardiac effects of mantle radiotherapy in patients with Hodgkin's disease, Ann. Oncol., 1, 355, 10.1093/oxfordjournals.annonc.a057774 Morgan, 1985, Late cardiac, thyroid and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease, Int. J. Radiat. Oncol. Biol. Phys., 11, 1925, 10.1016/0360-3016(85)90273-1 Van Leeuwan, 1994, Second cancer risk following Hodgkin's disease: a twenty year follow-up study, J. Clin. Oncol., 12, 312, 10.1200/JCO.1994.12.2.312 Hagemeister, 1990, Role of the gallium scan in Hodgkin's disease, Cancer, 65, 1090, 10.1002/1097-0142(19900301)65:5<1090::AID-CNCR2820650509>3.0.CO;2-# Henry-Amar, 1991, Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin's disease, Ann. Intern. Med., 114, 361, 10.7326/0003-4819-114-5-361 Hill, 1993, Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma, J. Clin. Oncol., 11, 2273, 10.1200/JCO.1993.11.11.2273 Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309 Hoh, 1997, PET in oncology: will it replace the other modalities?, Semin. Nucl. Med., 27, 94, 10.1016/S0001-2998(97)80042-6 Rahmouni, 1993, Lymphoma: monitoring tumor size and signal intensity with MR imaging, Radiology, 188, 445, 10.1148/radiology.188.2.8327695 Marsden, 1989, The performance of a multiwire proportional chamber positron camera for clinical use, Phys. Med. Biol., 34, 1043, 10.1088/0031-9155/34/8/007 Miller, 1981, Reporting results of cancer treatment, Cancer, 47, 207, 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6 Altman, 1991 Meyer, 1995, Diffusely increased colonic F-18 FDG uptake in acute enterocolitis, Clin. Nucl. Med., 20, 434, 10.1097/00003072-199505000-00012 Kubota, 1994, Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake, J. Nucl. Med., 35, 104 Haberkorn, 1991, PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy, J. Nucl. Med., 32, 1485 Engenhart, 1992, Therapy monitoring of presacral recurrences after high-dose irradiation, Strahlenther. Onkol., 168, 203 Haberkorn, 1992, Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy, J. Nucl. Med., 33, 1981 Minn, 1992, Uptake of 2-fluoro-2deoxy-D-[U-14C]-glucose during chemotherapy in murine Lewis lung tumor, Int. J. Rad. Appl. Instrum. B, 19, 55, 10.1016/0883-2897(92)90185-2 Strauss, 1996, Fluorine-18 deoxyglucose and false-positive results, Eur. J. Nucl. Med., 23, 1409, 10.1007/BF01367602 Lapela, 1995, Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose, Blood, 86, 3522, 10.1182/blood.V86.9.3522.bloodjournal8693522 de Wit, 1997, Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma, Ann. Oncol., 8, 57, 10.1093/annonc/8.suppl_1.S57 Bangerter, 1998, Role of whole body FDG-PET in predicting relapse in residual masses after treatment of lymphoma, Br. J. Haematol., 102, 148